Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure
Alberto Aimo(Scuola Superiore Sant'Anna), Michele Emdin(Scuola Superiore Sant'Anna), Rudolf A. de Boer(Erasmus MC), W.H. Wilson Tang(Cleveland Clinic), Giuseppe Vergaro(Scuola Superiore Sant'Anna), Justin L. Grodin(The University of Texas Southwestern Medical Center), Alan S. Maisel(San Francisco VA Medical Center), James L. Januzzi(Harvard University), Claudio Passino(Scuola Superiore Sant'Anna), Tobias Breidthardt, Hans‐Peter Brunner‐La Rocca(Inserm), Domingo A. Pascual‐Figal(Spanish National Centre for Cardiovascular Research), Johan Lassus(University of Helsinki), Étienne Gayat(Inserm), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Yuhui Zhang(Dalian University), Christian Mueller(University Hospital of Basel), Zaid Sabti(University Hospital of Basel), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Andrea Ripoli(Fondazione Toscana Gabriele Monasterio), Paulo Bettencourt(Universidade do Porto)
Cited by 156
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k